Creative Medical Technology Holdings (CELZ) Liabilities and Shareholders Equity (2016 - 2025)
Creative Medical Technology Holdings has reported Liabilities and Shareholders Equity over the past 16 years, most recently at $7.8 million for Q4 2025.
- Quarterly Liabilities and Shareholders Equity rose 17.1% to $7.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $29.1 million through Dec 2025, down 6.58% year-over-year, with the annual reading at $7.8 million for FY2025, 17.1% up from the prior year.
- Liabilities and Shareholders Equity was $7.8 million for Q4 2025 at Creative Medical Technology Holdings, up from $5.9 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $23.4 million in Q2 2022 and troughed at $732309.0 in Q2 2021.
- The 5-year median for Liabilities and Shareholders Equity is $9.0 million (2024), against an average of $10.2 million.
- Biggest five-year swings in Liabilities and Shareholders Equity: surged 3100.04% in 2022 and later plummeted 44.96% in 2024.
- Tracing CELZ's Liabilities and Shareholders Equity over 5 years: stood at $11.3 million in 2021, then surged by 70.27% to $19.2 million in 2022, then crashed by 44.15% to $10.7 million in 2023, then plummeted by 37.76% to $6.7 million in 2024, then increased by 17.1% to $7.8 million in 2025.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $7.8 million, $5.9 million, and $7.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.